Our lead product, the PleuraFlow® Active Tube Clearance® System is now available for marketing in the US, Canada and Europe. The board has worked with the executive team to lay out a strategy for the commercial roll out in 2011. The interest level by the surgeons and nurses is strong. The interest level by prospective distribution partners has been large and our global director of sales and marketing…
Read more
In October, 2010, the company announced it closed an equity financing round with total proceeds of $1.2 million. The financing was led by the Oregon Angel Fund (OAF), joined by additional Oregon based angel investors. The financing will support the clinical launch of the company’s lead product, the PleuraFlow® Active Tube Clearance® System and continued technology development.
Read more
Financing was led by the Oregon Angel Fund (OAF), joined by additional Oregon based angel investors, and will support the clinical launch of the companyʼs lead product.
Read more
and European Launch of the PleuraFlow Active Tube Clearance System
Read more
Demonstrating Improved Drainage with the PleuraFlow Active Tube Clearance System
Read more
In 2010, PleuraFlow® was awarded an international industrial design distinction award from I.D. Magazine.
Read more
The Bulletin
Read more
Innovation Award for its PleuraFlow Active Tube Clearance System
Read more
The company was awarded the prestigious 2009 European Association of Cardio-Thoracic Surgery (EACTS) Techno-College Innovation Award for its PleuraFlow® Active Tube Clearance® System. The Techno-College Award is a worldwide competition to identify innovations that have the potential to change the standard of care in heart and lung surgery. The award was established by the EACTS to recognize the most important technological breakthrough related to thoracic and cardiovascular surgery.
Read more
Today’s Medical Developments
Read more